Application and Implications of U.S. FDA “Animal Rule” in the Biodefence Drug Development
Wang Boyang, Gao Jin, Wang Zidong, Li Jie
Chinese Pharmaceutical Affairs ›› 2020, Vol. 34 ›› Issue (6) : 636-643.
Application and Implications of U.S. FDA “Animal Rule” in the Biodefence Drug Development
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
